CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Ordinary shares	Additional paid-in capital	Accumulated other comprehensive loss	Retained earnings (accumulated deficit)
Beginning balance (in shares) at Dec. 31, 2023		107,075,754
Beginning balance at Dec. 31, 2023	$ 362,496		$ 1,353,468	$ (5,469)	$ (985,503)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation to employees	34,084		34,084
Exercise of options and vested RSUs (in shares)		528,020
Exercise of options and vested RSUs	213		213
Other comprehensive income (loss), net of tax benefit of $0	1,322			1,322
Net income (loss)	(38,760)				(38,760)
Ending balance (in shares) at Mar. 31, 2024		107,603,774
Ending balance at Mar. 31, 2024	359,355		1,387,765	(4,147)	(1,024,263)
Beginning balance (in shares) at Dec. 31, 2023		107,075,754
Beginning balance at Dec. 31, 2023	362,496		1,353,468	(5,469)	(985,503)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(168,627)
Ending balance (in shares) at Dec. 31, 2024		108,516,819
Ending balance at Dec. 31, 2024	360,179		1,519,809	(5,500)	(1,154,130)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation to employees	29,552		29,552
Exercise of options and vested RSUs (in shares)		2,965,781
Exercise of options and vested RSUs	5,247		5,247
Other comprehensive income (loss), net of tax benefit of $0	1,299			1,299
Net income (loss)	(34,319)				(34,319)
Ending balance (in shares) at Mar. 31, 2025		111,482,600
Ending balance at Mar. 31, 2025	$ 361,958		$ 1,554,608	$ (4,201)	$ (1,188,449)